喘乐宁氧气雾化吸入治疗COPD急性加重期疗效观察被引量：3

Therapeutic Effect of Nebulizations of Ventolin Oxygen Inbreathe on Acute Exacerbations of Chronic Obstructive Pulmonary Disease

下载PDF

导出

摘要目的观察氧气雾化吸入喘乐宁治疗慢性阻塞性肺疾病(COPD)急性加重期患者的疗效。方法62例COPD急性加重期患者随机分为对照组(28例)和治疗组(34例)。两组均予吸氧、抗感染、祛痰、解痉等对症治疗。治疗组加用喘乐宁氧气雾化吸入。观察两组患者治疗前后症状、体征及动脉血气变化。结果治疗组治疗总有效率高于对照组(P<0.05),血气指标的改善优于对照组(P<0.05)。结论氧气雾化吸入喘乐宁是治疗COPD急性加重期的一种有效方法。 Objective To observe the therapeutic effect of nebulizations of ventolin oxygen inbreathe on acute exacerbations of chron/c obstructive pulmonary disease （COPD）. Methods 62 patients with COPD were randomly divided into two groups （the treatment group 28 and the control group 34）. The basic regimens for the two groups were oxygen, antibiotics, expectorants, and bronchodilators. The treatment group was given nebulizations of ventolin oxygen inbreathe. The therapentic effects on symptoms and signs as well as arterial blood gas of the two groups were observed before and after treatment. Results The total effective rate was much higher in the treatment group than in the control group （P〈0.05）.the improvement of blood gas in treatment group was superior to that in the control group （P〈0.05）. Conclusion The nebulizations of ventolin oxygen inbreathe is one of the best ways of curing acute exacerbations of COPD.

作者陈小红肖明桂庆军尹凯李熠

机构地区永州职业技术学院附属医院南华大学医学院

出处《南华大学学报（医学版）》 2008年第3期375-377,共3页 Journal of Nanhua University(Medical Edition)

关键词慢性阻塞性肺疾病喘乐宁血气分析 chronic obstructive pulmonary disease ventolin blood gas analysis

分类号 R563 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献5

1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量：5103
2陈灏珠.实用内科学.第11版[M].北京:人民卫生出版社,2001.1402.
3谷秀,李胜岐,佐久间勉.β肾上腺素能受体激动剂对离体大鼠肺泡液体清除率的作用[J].中华结核和呼吸杂志,2005,28(6):390-393. 被引量：15
4Jaeschke R, Guyall GH, Willan A, et al. The effect of increasing doses of betaagonists on spirometry, exercise capacity, and quality of life in patients with chronic airflow limitation [ J ]. Thorax, 1994,49:478.
5Mahler DA. The effect of inhaled beta 2-agonists on clinical outcomes in chronic obstructive pulmonary disease [ J ]. Journal of Allergy &Clinical Immunology, 2002, 110 ( 6 Suppl ) : s298 - s303.

二级参考文献8

1Matthay MA,Folkesson HG,Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev,2002,82:569-600.
2Berthiaume Y,Staub NC,Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest,1987,79:335-343.
3Lasnier JM,Wangensteen OD,Schmitz LS,et al. Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol,1996,81:1723-1729.
4Icard P,Saumon G. Alveolar sodium and liquid transport in mice. Am J Physiol,1999,277(6 Pt 1):L1232-L1238.
5Sakuma T,Tuchihara C,Ishigaki M,et al. Denopamine,a beta(1)-adrenergic agonist,increases alveolar fluid clearance in ex vivo rat and guinea pig lungs. J Appl Physiol,2001,90:10-16.
6Sakuma T,Tuchihara C,Ishigaki M,et al. Beta1-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lun. Exp Lung Res,2001,27:453-468.
7Matthay MA,Folkesson HG,Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol,1996,270(4 Pt 1):L487-L503.
8Sakuma T,Pittet JF,Jayr C,et al. Alveolar liquid and protein clearance in the absence of blood flow or ventilation in sheep. J Appl Physiol,1993,74:176-185.